Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy

Hamzah Khan(St. Michael's Hospital), Mohammad Qadura(St. Michael's Hospital), Muzammil H. Syed(St. Michael's Hospital), Omar Kanny(St. Michael's Hospital)

International Journal of Molecular Sciences

September 26, 2022

10.3390/ijms231911317

Cited by 41

Related Papers

Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies

|Stem Cells|2017|205

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response

|Blood|2008|82

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

|Blood|2009|63

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease

|Journal of Clinical Medicine|2020|62

Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis

|Scientific Reports|2020|57